Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Nasopharyngeal Carcinoma

ribavirin has been researched along with Nasopharyngeal Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brait, M; Brem, H; Casaos, J; Cecia, A; Ding, AS; Ehresman, J; Gorelick, NL; Huq, S; Ishida, W; Ji, C; Kedda, JN; Morales, M; Perdomo-Pantoja, A; Peters, M; Serra, R; Sidransky, D; Skuli, N; Suk, I; Tyler, B; Xia, Y; Zhao, T1
Jiang, Y; Qu, M; Tao, Z; Wang, S; Xu, M1
Han, Q; Hu, Z; Hua, Q; Li, Q; Zhen, L1

Other Studies

3 other study(ies) available for ribavirin and Nasopharyngeal Carcinoma

ArticleYear
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:9

    Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Drug Repositioning; Enhancer of Zeste Homolog 2 Protein; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; IMP Dehydrogenase; Mice; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation-Sensitizing Agents; Ribavirin; Snail Family Transcription Factors; Xenograft Model Antitumor Assays

2020
Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
    Biochemical and biophysical research communications, 2019, 05-14, Volume: 512, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Humans; Mice, SCID; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Oncogenes; Phosphorylation; Protein Biosynthesis; Ribavirin; Serine

2019
Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation.
    Biochemical and biophysical research communications, 2019, 06-11, Volume: 513, Issue:4

    Topics: Animals; Cell Line, Tumor; Epithelial Cells; Eukaryotic Initiation Factor-4E; Extracellular Signal-Regulated MAP Kinases; Fluorouracil; Humans; Mice; Nasopharyngeal Carcinoma; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribavirin; Signal Transduction; Xenograft Model Antitumor Assays

2019